Traditional Chinese medicine composition for treating schizophrenia and mania

Abstract

The invention discloses a traditional Chinese medicine composition for treating schizophrenia and mania, and belongs to the technical field of a traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following ingredients in parts by weight: 10 to 15 parts of rhizoma pinelliae, 5 to 10 parts of radix gentianae scabrae bunge, 5 to 10 parts of fructus aurantii immaturus, 20 to 30 parts of cornu bubali, 5 to 10 parts of radix scutellariae, 20 to 30 parts of snakegourd seeds, 5 to 10 parts of rhizoma acori tatarinowii, 10 to 15 parts of white paeony roots, 25 to 30 parts of radish seeds, 5 to 10 parts of arisaema cum bile, 5 to 10 parts of semen brassicae albae, 5 to 10 parts of poria cocos, 5 to 10 parts of dried orange peel, 5 to 10 partsof flos gardeniae, 5 to 10 parts of radix angelicae sinensis, 5 to 10 parts of liquorice roots, 10 to 15 parts of rhizoma gastrodiae, 5 to 10 parts of semen ziziphi spinosae, 10 to 15 parts of dwarf lilyturf roots, 10 to 15 parts of radix et rhizoma rhei and 10 to 15 parts of rhizoma zingiber officinale. The traditional Chinese medicine composition has the advantages that the effect taking is fast; the treatment effect is good; pathogenic obesity cannot be easily caused, and the like.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating schizophrenia and mania. Background technique [0002] Schizophrenia is a severe mental illness of unknown etiology, mostly in young adults with slow or subacute onset, clinically manifested as a syndrome with various symptoms, involving obstacles in perception, thinking, emotion, and behavior and incoordination of mental activity. Patients generally have clear consciousness and basically normal intelligence, but some patients may experience cognitive impairment during the course of the disease. The course of the disease is generally protracted, showing recurrent attacks, aggravation or deterioration, and some patients eventually develop decline and mental disability, but some patients can maintain recovery or basically recovery after treatment. [0003] 1. Clinical manifestations [0004...

AI Technical Summary

Problems solved by technology

[0008] (4) Most patients with volition and behavior disorders have decreased or even lack of volition, manifested as reduced activities, solitude, passive behavior, lack of due enthusiasm and initiative, decreased interest in work and study, no concern for the future, and no hope for the future Definitely intend, some patients may have some plans and intentions, but they are rarely executed

[0009] (5) Cognitive dysfunction The incidence of cognitive deficits in patients with schizophrenia is high, and about 85% of patients have cognitive dysfunction, such as information processing and selective attention, working memory, short-term memory and learning, executive function Cognitive deficits

[0018] (3) Can't stop talking

[0020] (5) Easily distracted

[0028] Antipsychotic drugs may cause pathogenic obesity. According to different constitutions, most patients will experience a weight gain of 5%-20%, and a few patients may even experience a weight gain of more than 30%. Pathogenic obesity will not only lead to functional decline in patients , prone to three high-level complications, but also cause psychological burden to patients, which is not conducive to treatment

[0029] In addition, regardless of the treatment of schizophrenia or mania, antipsychotic drugs are more expensive, and may have side effects (such as retching, weakness, etc.), and may need to be used in combination with other drugs, such as risperidone needs to be combined with hydrochloric acid Benheyxol use